Aster DM’s stock spurts ~11% as PAT jumps by a whopping 238% yoy in FY22

PAT for Q4FY22 (Pre Non-Controlling Interest) increased to Rs246 crore.

May 25, 2022 11:21 IST | India Infoline News Service
Aster DM Healthcare’s counter jumped nearly 12% in today’s trade after the company announced its results for the quarter and financial year ended March 31, 2022.

Company’s revenue from operations logged growth of 14% yoy at Rs2,728 crore in Q4FY22, as against Rs2,391 crore in Q4FY21. While revenue for FY22 jumped 19% yoy at Rs10,253 crore as against Rs8,608 crore in FY21.

EBITDA for FY22 jumped 40% yoy at Rs1,483 crore as compared to Rs1,063 crore in FY21. For Q4FY22, the company’s EBITDA increased 44% yoy at Rs463 crore as against Rs321 crore in Q4FY21.

PAT for Q4FY22 (Pre Non-Controlling Interest) increased to Rs246 crore, up 110% yoy as compared to Rs117 crore in the same period, the previous financial year.

PAT for FY22 increased significantly by 238% yoy at Rs601 crore as compared to Rs178 crore in FY21.

At around 11.18 AM, Aster DM’s counter was trading 10.83% or Rs18.70 higher at Rs191.40, as against the previous close of Rs172.70 on BSE. It opened at Rs184 and touched intraday high and low of Rs197.20 and Rs184 respectively so far.

FREE Benefits Worth 5,000



Open Demat Account

  • 0

    Per Order for ETF & Mutual Funds Brokerage

  • 20

    Per Order for Delivery, Intraday, F&O, Currency & Commodity